Access
This article is part of Nature's premium content.
Published online 7 January 2009 | Nature 457, 136-137 (2009) | doi:10.1038/457136a
News
Biotechs feel the pain
The biotechnology industry is weathering the financial crisis better than some. That doesn't mean it's in great shape, reports Heidi Ledford.
For the past decade, the annual MassBio Investors Forum has been the place for Massachusetts biotechnology companies to network and woo new investors. But although the courtship continued last month at the Sheraton Boston hotel, the meeting rooms were also filled with investors and executives taking a crash course in how to survive the current economic climate.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
